XB-ART-58539
Elife
2021 Sep 30;10. doi: 10.7554/eLife.60682.
Show Gene links
Show Anatomy links
Mutational analysis to explore long-range allosteric couplings involved in a pentameric channel receptor pre-activation and activation.
Lefebvre SN
,
Taly A
,
Menny A
,
Medjebeur K
,
Corringer PJ
.
???displayArticle.abstract???
Pentameric ligand-gated ion channels (pLGICs) mediate chemical signaling through a succession of allosteric transitions that are yet not completely understood as intermediate states remain poorly characterized by structural approaches. In a previous study on the prototypic bacterial proton-gated channel GLIC, we generated several fluorescent sensors of the protein conformation that report a fast transition to a pre-active state, which precedes the slower process of activation with pore opening. Here, we explored the phenotype of a series of allosteric mutations, using simultaneous steady-state fluorescence and electrophysiological measurements over a broad pH range. Our data, fitted to a three-state Monod-Wyman-Changeux model, show that mutations at the subunit interface in the extracellular domain (ECD) principally alter pre-activation, while mutations in the lower ECD and in the transmembrane domain principally alter activation. We also show that propofol alters both transitions. Data are discussed in the framework of transition pathways generated by normal mode analysis (iModFit). It further supports that pre-activation involves major quaternary compaction of the ECD, and suggests that activation involves principally a reorganization of a 'central gating region' involving a contraction of the ECD β-sandwich and the tilt of the channel lining M2 helix.
???displayArticle.pubmedLink??? 34590583
???displayArticle.pmcLink??? PMC8504973
???displayArticle.link??? Elife
Species referenced: Xenopus laevis
Genes referenced: ecd ttn twist1
GO keywords: ligand-gated ion channel activity
???attribute.lit??? ???displayArticles.show???
Figure 1. Electrophysiological and fluorescence characterization of the quenching pairs of GLIC. (A) Scheme for GLIC activation, showing first a pre-activation step involving full compaction of the ECD and motion of the M2-M3 loop as monitored by fluorescence, followed by a pore opening step. Blue spheres indicate the location of sensors Bim136-Q101W and Bim250-Y197 used thereafter in this study. (B) GLIC-pH 4 (pdb code 4HFI) structure side view, the light blue rectangle represents the position of the membrane. Quenching pairs generated in our previous study (Menny et al., 2017) are highlighted: blue spheres show the Cα of the residues that were mutated into cysteines and bimane labeled (Bim33, Bim133, Bim135, Bim136, and Bim250), black spheres show the Cα of the quenchers (W160, L103W, W72, Q101W, and Y197). (C) pH-dependent response curves of Bim136-Q101W and Bim250-Y197 sensors, by electrophysiology after labeling (top panel) and with bimane fluorescence quenching (lower two panels). Fluorescence data are shown normalized to the fluorescence of the denatured protein (FSDS), bimane fluorescence is shown without quencher (○) and in presence of the quencher (●). ECD, extracellular domain. | |
Figure 2. Allosteric coupling within the ECD. (A) Structure of two monomers of GLIC pH 4 (4HFI) showing positions of the fluorescence sensor (Bim136-Q101W) and the two mutated residues at the bottom of the ECD resulting in a partial loss of function. The lower panel shows a zoom on the interface with E26 and Y28 residues and their interactions with surrounding residues and a network of water molecules (blue spheres). (B) Electrophysiological recordings in oocytes of the mutants labeled with bimane showing shifted responses to higher proton concentrations in comparison with GLIC Bim136-Q101W. pH applications are shown above each trace and the horizontal scale represents 1 min of recording. Graphs represent pH-dependent curves showing a shift to higher proton concentrations in electrophysiological responses (C) and fluorescence quenching responses (D) for both mutants. ECD, extracellular domain. | |
Figure 3.Allosteric coupling between the top of the ECD and the TMD. (A) Structure of two monomers of GLIC pH 4 (4HFI) showing positions of the fluorescence sensor (Bim136-Q101W) at the top of the ECD and three mutations distributed along the protein. Right panels show zooms on important interactions with the mutated residues. (B) Electrophysiological recordings of the three mutants in oocytes, labeled with bimane. Recording of GLIC Bim136-Q101W is shown for comparison. pH applications are shown above each trace and the horizontal scale represents 1 min of recording. pH-dependent curves for electrophysiological response (C) and fluorescence quenching (D) for the three mutants in comparison with Bim136-Q101W showing a shift to higher proton concentrations of the response for all three mutants. ECD, extracellular domain; TMD, transmembrane domain. | |
Figure 4. Non-functional mutants differentially alter ECD and TMD motions. (A) Structure of two monomers of GLIC pH 4 showing the position of the fluorescence sensors (Bim136-Q101W and Bim250-Y197) and three mutations causing a total loss of function. (B) Zooms on important re-organizations of the mutated residues between structures at pH 4 (4HFI-gray) and pH 7 (4NPQ-black). (C) Electrophysiological recordings in oocytes of the three mutants labeled with bimane showing no current in comparison with GLIC presenting sensor mutations only. pH-dependent curves in fluorescence for the three mutants with the sensor Bim136-Q101W (D) and Bim250-Y197 (E). ECD, extracellular domain; TMD, transmembrane domain. | |
Figure 5. Allosteric coupling between the top of the ECD and propofol binding. (A) Structure of two monomers of GLIC pH 4 showing positions of the fluorescence sensor Bim136-Q101W at the top of the ECD and three propofol binding sites intra, inter-subunit, and in the pore identified by X-ray crystallography (Fourati et al., 2018). (B) Example of electrophysiological response to 100 μM propofol during a low pH application (scale bars represent 100 nA and 30 s). (C) Electrophysiological pH-dependent curves of Bim136-Q101W with (◆) and without (●) the H235Q mutation showing inhibition and potentiation, respectively. (D) Effect of 100 μM propofol on fluorescence quenching without (top panel) and with H235Q mutation (lower panel) for the Bim136-Q101W sensor. ECD, extracellular domain. | |
Figure 6. The three-state MWC model fits experimental data for Bim136Q101W mutants. (A) Scheme showing the three states and parameters of the model. (B) Table with multiplication factors of isomerization constants for pre-activation and activation as compared to Bim136-Q101W. For the Bim136-Q101W-H235Q in presence of propofol, the multiplication factors are given in comparison with Bim136-Q101W-H235Q. Isomerization constants of Bim136-Q101W and Bim136-Q101W-H235Q are shown above the table (see full table in Figure 6—figure supplement 2—source data 1). (C) Superposition of experimental data points and theoretical curves. Data points shown as spheres correspond to fluorescence intensities normalized on FSDS (blue, ◆), and to electrophysiological response normalized to the maximal current in (black, ●) except H235Q without propofol for which values were normalized to the values in the presence of propofol. Theoretical curves: the population of A state is shown in black lines and the fluorescence curve (blue line) is calculated from the sum of the three states’ fractional populations weighted by their intrinsic fluorescence intensity (see formula in Materials and methods section). For each mutant, the fit from Bim136-Q101W (Bim136-Q101W-H235Q for the last panel) is shown in dotted blue and black lines for a visual comparison and arrows are illustrating the shift in pH50. MWC, Monod-Wyman-Changeux. | |
Figure 7. The three-state MWC model fits experimental data for total loss of function mutants. Data are presented as in Figure 6. (A) Multiplication factors of isomerization constants for pre-activation and activation of total loss of function mutants as compared to sensors Bim136-Q101W and Bim250-Y197. (B) Superposition of experimental data points and theoretical curves. Data points (in spheres) correspond to fluorescence intensities normalized on FSDS (blue ◆), and to electrophysiological response normalized to the maximal current (black, ●). Theoretical curves: the population of A state is shown in black lines for sensors and the fluorescence curve (blue line) is calculated from the sum of the three states’ fractional populations weighted by their intrinsic fluorescence intensity. For each mutant, the fit from the associated sensors (Bim136-Q101W or Bim250 Y197) is shown in dotted lines for a visual comparison and arrows are illustrating the shift in pH50. MWC, Monod-Wyman-Changeux. | |
Figure 8. Two distinct trajectories for GLIC activation computed using iMODfit. (A) RMSD evolution throughout the frames of trajectories A and B against GLIC structures at pH 4 (●); pH 7 (▲), pdb codes are 4HFI and 4NPQ, respectively. Both trajectories are shown with frame one being the closest to GLIC-pH 7. (B) Twist angle measured throughout the frames on both trajectories. The twist angle is measured by the angle formed between vectors from the centers of mass of the ECD and TMD as defined in Calimet et al., 2013. Each trace corresponds to the trajectory of a single subunit within the pentamer. | |
Figure 9. Key TMD motions in trajectories A and B. (A) Snapshots of GLIC TMD top view in the first and last frame of the trajectory A with a Bim250-Y197 quenching pair modeled at one interface. Bimane is shown in blue and Y197 in black spheres. One subunit is shown in gray, the others are in white, the M2-M3 loop is shown in blue, and the loop 2 from ECD is shown in purple for one subunit. Atoms used for measurements are shown in pale blue spheres and distances are indicated in angstroms. (B) Pore radius measured at the Ile233 level. (C) Intra-subunit separation of M2 and M3 helices measured between atoms indicated. Points at positions 0 and 13 are the distances measured in pH 4 and pH 7 X-ray structures. (D) Inter-subunit distances showing M2-M3 loop outward motion at the Pro250-Tyr197 level (top panel) and between bimane and Tyr197 centroids (bottom panel) in both trajectories A and B. ECD, extracellular domain; TMD, transmembrane domain. | |
Figure 10. Key ECD motions in trajectories A and B. (A) Snapshots of two subunits of GLIC ECD in the first and last frame of the trajectory A with a Bim136-Q101W quenching pair modeled at the interface. One subunit is shown in gray, the other in white with sheets of the β-sandwich shown in dark and light purple; bimane is shown in blue and Trp101 in black spheres; Cα and Cβ atoms used for measurements are shown in pale blue spheres and distances are indicated in angstroms. Inter-subunit distances showing ECD compaction measured at the Asp136-Gln101 level (B) and between bimane and Q101W centroids (C) in both trajectories A and B. Points at frames 0 and 13 are the distances in pH 4 and pH 7 X-ray structures. (D) Intra-subunit distance showing contraction at the bottom of the β-sandwich measured by Cα distances between Asp32 and Gly159. ECD, extracellular domain. | |
Figure 11. Effect of mutations on pre-activation and activation. (A) One subunit of GLIC showing the positions of tested mutations in red spheres, with in gray the region involved in the central gating pathway identified by iModFit. (B) Multiplication factor shown on a log scale for each mutant to visualize how isomerization constants LpA and LA were modified in comparison with Bim136-Q101W, or for propofol (H235Q) in comparison with the same mutant without propofol. | |
Figure 1—figure supplement 2. pH-dependent curves comparison.Normalized pH-dependent curves in electrophysiological response (black, ●) and fluorescence quenching (blue, ◆) showing that fluorescence pH50 is higher than current pH50 for both sensors Bim136-Q101W and Bim250-Y197. For the fluorescence quenching data, the value at neutral pH is set to 0 and values are then normalized to the value displaying the maximal change in fluorescence. | |
Figure 6—figure supplement 2. A simplified two-state MWC model to fit the total loss of function mutant H235F.(A) Two-state model and parameters used in the model and their fixed values. (B) Superposition of experimental data points (fluorescence quenching normalized on FSDS), and theoretical fluorescence curve calculated from the two states weighted by their intrinsic fluorescence intensity. MWC, Monod-Wyman-Changeux. Figure 6—figure supplement 2—source data 1. Summary of isomerization constant set for each mutant.To test the robustness of the fitting, the model was tested starting with the isomerization constant of LpA from Bim136-Q101W-H235F set at 100, 1000, or 100,000. The multiplication factor is calculated in comparison with Bim136-Q101W constants except for H235Q + propofol (compared to Bim136-Q101W-H235Q) and mutations on Bim250-Y197 sensor background (compared to Bim250-Y197). LpA constant was averaged on the 3 LpA values. Affinity constants used for the second binding site were K’R=5×10−5, K’pA=5×10−5, and K’A=5×10−6, affinity constants of the first binding site are shown in the table for the different LpA values and fluorescence values for each state are indicated in Figure 6—figure supplement 2. To assess how well our model fits the experimental values, the determination coefficient (R2) was calculated for each mutant with the different LpA and corresponding affinities. R2 was calculated for both fluorescence quenching (R2 Fluo) and electrophysiological response (R2 current). | |
Figure 10—figure supplement 2. Evolution of ECD inter-subunits distance Lys33-Trp160 at the bottom of the ECD in iMODfit trajectories.(A) Snapshots of two subunits of GLIC ECD in the first and last frame of the trajectory A with Bim33-W160 quenching pair modeled. One subunit is shown in gray, the other in white with β-sheets forming the β-sandwich shown in dark and light purple; bimane is shown in blue and quencher in black spheres; Cβ atoms used for measurements are shown in pale blue spheres and distances are indicated in angstroms. (B) Inter-subunit distances showing ECD compaction at the Lys33-Trp160 level (top panel) and between bimane and W160 centers of mass (bottom panel) in both trajectories A and B. Points at frames 0 and 13 are the distances in pH 4 and pH 7 structures subunits interfaces. ECD, extracellular domain. | |
Figure 10—figure supplement 3. Evolution of Bim135-W72 orientation at the ECD intra-subunits in iMODfit trajectories.(A) Snapshots of one subunit of GLIC ECD, top view in the first and last frame of the trajectory A with Bim135-W72 quenching pair modeled. The adjacent subunit is shown in gray, and the main subunit is shown in white with β-sheets forming the β-sandwich shown in dark and light purple; bimane is shown in blue and quencher in black spheres. (B) Snapshots for the trajectory B. (C) Similar representation from the structure resolved by X-ray of Bim135-W72 at pH 4 (5IUX). Bimane was resolved in two out of five chains and showed a similar orientation to the one found in the last frames of both trajectories (A and B right panels). (D) Intra-subunit Cβ distances between Val135 and Trp72 (top panel) and between Bim135 and Trp72 centers of mass (bottom panel) along the trajectories. Conclusion for Bim135-W72, the distances between the centers of mass of the bimane and indole moieties are not correlated with the distances between the residue’s backbone. Since at this position bimane occupies a rather buried location within the protein structure, we suggest that these discrepancies come from local reorganization of surrounding residues that are not directly correlated with the movement of the backbone. Interestingly, we previously solved the X-ray structure of Bim135-W72 at pH 4 by crystallography, which shows a similar location of the bimane moiety with that of our docking in GLIC-pH 4. ECD, extracellular domain. |
References [+] :
Althoff,
X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors.
2014, Pubmed
Althoff, X-ray structures of GluCl in apo states reveal a gating mechanism of Cys-loop receptors. 2014, Pubmed
Bahar, Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins. 2010, Pubmed
Bertozzi, Signal Transduction at the Domain Interface of Prokaryotic Pentameric Ligand-Gated Ion Channels. 2016, Pubmed , Xenbase
Bocquet, A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family. 2007, Pubmed , Xenbase
Bocquet, X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. 2009, Pubmed
Bode, The impact of human hyperekplexia mutations on glycine receptor structure and function. 2014, Pubmed
Calimet, A gating mechanism of pentameric ligand-gated ion channels. 2013, Pubmed
Carswell, Intramembrane aromatic interactions influence the lipid sensitivities of pentameric ligand-gated ion channels. 2015, Pubmed
Cheng, Molecular dynamics and brownian dynamics investigation of ion permeation and anesthetic halothane effects on a proton-gated ion channel. 2010, Pubmed
Du, Glycine receptor mechanism elucidated by electron cryo-microscopy. 2015, Pubmed
Duret, Functional prokaryotic-eukaryotic chimera from the pentameric ligand-gated ion channel family. 2011, Pubmed , Xenbase
Elenes, Desensitization of diliganded mouse muscle nicotinic acetylcholine receptor channels. 2002, Pubmed
Esmenjaud, An inter-dimer allosteric switch controls NMDA receptor activity. 2019, Pubmed , Xenbase
Fourati, Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels. 2018, Pubmed , Xenbase
Fritsch, Ion selectivity mechanism in a bacterial pentameric ligand-gated ion channel. 2011, Pubmed
Galzi, The multiple phenotypes of allosteric receptor mutants. 1996, Pubmed
Gharpure, Agonist Selectivity and Ion Permeation in the α3β4 Ganglionic Nicotinic Receptor. 2019, Pubmed
Ghosh, A chimeric prokaryotic-eukaryotic pentameric ligand gated ion channel reveals interactions between the extracellular and transmembrane domains shape neurosteroid modulation. 2017, Pubmed , Xenbase
Gielen, The desensitization pathway of GABAA receptors, one subunit at a time. 2020, Pubmed , Xenbase
Gonzalez-Gutierrez, Chasing the open-state structure of pentameric ligand-gated ion channels. 2017, Pubmed
Gupta, A mechanism for acetylcholine receptor gating based on structure, coupling, phi, and flip. 2017, Pubmed
Heidmann, Interaction of a fluorescent agonist with the membrane-bound acetylcholine receptor from Torpedo marmorata in the millisecond time range: resolution of an "intermediate" conformational transition and evidence for positive cooperative effects. 1980, Pubmed
Hernandez, A structural look at GABAA receptor mutations linked to epilepsy syndromes. 2019, Pubmed
Heusser, Allosteric potentiation of a ligand-gated ion channel is mediated by access to a deep membrane-facing cavity. 2018, Pubmed
Hilf, X-ray structure of a prokaryotic pentameric ligand-gated ion channel. 2008, Pubmed
Hu, Crystal structures of a pentameric ion channel gated by alkaline pH show a widely open pore and identify a cavity for modulation. 2018, Pubmed
Hu, Structural basis for allosteric transitions of a multidomain pentameric ligand-gated ion channel. 2020, Pubmed , Xenbase
Jaiteh, Evolution of Pentameric Ligand-Gated Ion Channels: Pro-Loop Receptors. 2016, Pubmed
Johannesen, Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies. 2016, Pubmed , Xenbase
Jones Brunette, Distance mapping in proteins using fluorescence spectroscopy: tyrosine, like tryptophan, quenches bimane fluorescence in a distance-dependent manner. 2014, Pubmed
Koes, Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. 2013, Pubmed
Krivov, Improved prediction of protein side-chain conformations with SCWRL4. 2009, Pubmed
Laha, Macroscopic kinetics of pentameric ligand gated ion channels: comparisons between two prokaryotic channels and one eukaryotic channel. 2013, Pubmed , Xenbase
Lape, On the nature of partial agonism in the nicotinic receptor superfamily. 2008, Pubmed
Lape, The α1K276E startle disease mutation reveals multiple intermediate states in the gating of glycine receptors. 2012, Pubmed
Laverty, Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites. 2017, Pubmed
Lev, String method solution of the gating pathways for a pentameric ligand-gated ion channel. 2017, Pubmed
Lopéz-Blanco, iMODFIT: efficient and robust flexible fitting based on vibrational analysis in internal coordinates. 2013, Pubmed
Mansoor, Mapping proximity within proteins using fluorescence spectroscopy. A study of T4 lysozyme showing that tryptophan residues quench bimane fluorescence. 2002, Pubmed
Mansoor, Distance mapping in proteins using fluorescence spectroscopy: the tryptophan-induced quenching (TrIQ) method. 2010, Pubmed
Masiulis, GABAA receptor signalling mechanisms revealed by structural pharmacology. 2019, Pubmed
Menny, Identification of a pre-active conformation of a pentameric channel receptor. 2017, Pubmed , Xenbase
Moraga-Cid, Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure. 2015, Pubmed
Mukhtasimova, Detection and trapping of intermediate states priming nicotinic receptor channel opening. 2009, Pubmed
Nemecz, Emerging Molecular Mechanisms of Signal Transduction in Pentameric Ligand-Gated Ion Channels. 2016, Pubmed
Nemecz, Full mutational mapping of titratable residues helps to identify proton-sensors involved in the control of channel gating in the Gloeobacter violaceus pentameric ligand-gated ion channel. 2017, Pubmed
Nury, Crystal structure of the extracellular domain of a bacterial ligand-gated ion channel. 2010, Pubmed
Nury, X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. 2011, Pubmed
Orellana, Prediction and validation of protein intermediate states from structurally rich ensembles and coarse-grained simulations. 2016, Pubmed
Parikh, Structure of the M2 transmembrane segment of GLIC, a prokaryotic Cys loop receptor homologue from Gloeobacter violaceus, probed by substituted cysteine accessibility. 2011, Pubmed
Plested, Single-channel study of the spasmodic mutation alpha1A52S in recombinant rat glycine receptors. 2007, Pubmed
Plested, Don't flip out: AChRs are primed to catch and hold your attention. 2014, Pubmed
Polovinkin, Conformational transitions of the serotonin 5-HT3 receptor. 2018, Pubmed
Pravda, MOLEonline: a web-based tool for analyzing channels, tunnels and pores (2018 update). 2018, Pubmed
Prevost, A locally closed conformation of a bacterial pentameric proton-gated ion channel. 2012, Pubmed
Prevost, Intermediate closed state for glycine receptor function revealed by cysteine cross-linking. 2013, Pubmed , Xenbase
Rienzo, Structural requirements in the transmembrane domain of GLIC revealed by incorporation of noncanonical histidine analogs. 2014, Pubmed , Xenbase
Rienzo, Perturbation of Critical Prolines in Gloeobacter violaceus Ligand-gated Ion Channel (GLIC) Supports Conserved Gating Motions among Cys-loop Receptors. 2016, Pubmed , Xenbase
Rovšnik, Dynamic closed states of a ligand-gated ion channel captured by cryo-EM and simulations. 2021, Pubmed
Sakmann, Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist. 1980, Pubmed
Sauguet, Structural basis for ion permeation mechanism in pentameric ligand-gated ion channels. 2013, Pubmed , Xenbase
Sauguet, Crystal structures of a pentameric ligand-gated ion channel provide a mechanism for activation. 2014, Pubmed , Xenbase
Sauguet, Crystallographic studies of pharmacological sites in pentameric ligand-gated ion channels. 2015, Pubmed
Saul, Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating. 1999, Pubmed
Schmandt, A chimeric prokaryotic pentameric ligand-gated channel reveals distinct pathways of activation. 2015, Pubmed , Xenbase
Sehnal, MOLE 2.0: advanced approach for analysis of biomacromolecular channels. 2013, Pubmed
Shen, Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating. 2008, Pubmed
Taly, Normal mode analysis suggests a quaternary twist model for the nicotinic receptor gating mechanism. 2005, Pubmed
Taly, Functional organization and conformational dynamics of the nicotinic receptor: a plausible structural interpretation of myasthenic mutations. 2008, Pubmed
Yu, Mechanism of gating and partial agonist action in the glycine receptor. 2021, Pubmed
Zimmermann, Ligand activation of the prokaryotic pentameric ligand-gated ion channel ELIC. 2011, Pubmed